热re99久久精品国99热线看-中国女人黄色片-日本精品久久久久久久,国产精品888,天天躁日日躁狠狠躁图片swag ,精品国产乱码久久久久久丨区2区

重組膠原蛋白的產業發展歷程和生物醫學應用前景展望
日期:2023-06-01 11:07
狀態:待解決
提問:kjcxac
calTrials.gov/show/NCT03752905 (2020-10-20). https://clinicaltrials.gov/show/NCT03752905
[98]Supp DM, Hahn JM, Combs KA, et al. Collagen VII expression is required in both keratinocytes and fibroblasts for anchoring fibril formation in bilayer engineered skin substitutes. Cell Transplant, 2019, 28(9/10): 1242-1256.
[99]Khl T, Mezger M, Hausser I, et al. Collagen VII half-life at the dermal-epidermal junction zone: implications for mechanisms and therapy of genodermatoses. J Invest Dermatol, 20
最佳答案:
暫無最佳答案
[全部回答(0)] [我來回答]
97/100 下一頁 上一頁 首頁 尾頁
返回 |  刷新 |  WAP首頁 |  網頁版  | 登錄
08/22 05:29